-
中文名稱：人前列腺素E2(PGE2)酶聯免疫試劑盒
-
貨號：CSB-E07965h
-
規格：96T/48T
-
價格：￥3600/￥2500
-
其他：
產品詳情
-
產品描述：人前列腺素E2(PGE2)酶聯免疫試劑盒（CSB-E07965h）為競爭法ELISA試劑盒，定量檢測血清、血漿、組織勻漿樣本中的PG-E2含量。PG-E2（前列腺素 E2）是一種生物活性脂質介質。它在炎癥反應、免疫調節、組織修復等多種生理和病理過程中發揮重要作用。其研究機制主要聚焦于與特定受體結合，激活細胞內信號通路，從而影響細胞的增殖、分化和功能，對相關疾病治療研究有重要意義。試劑盒檢測范圍為1.5 pg/mL-300 pg/mL，本試劑盒可為體外研究炎癥介導機制、免疫調節通路、藥物干預效果評估等提供可靠數據支持，特別適用于實驗室條件下探索生物樣本中PGE2的動態變化規律，滿足細胞實驗、動物模型或離體組織分析等基礎科研需求。本品僅用于科研，不用于臨床診斷，產品具體參數及操作步驟詳見產品說明書。
-
縮寫：PG-E2
-
種屬：Homo sapiens (Human)
-
樣本類型：serum, plasma, tissue homogenates
-
檢測范圍：1.5 pg/mL-300 pg/mL
-
靈敏度：0.75 pg/mL
-
反應時間：1-5h
-
樣本體積：50-100ul
-
檢測波長：450 nm
-
研究領域：Signal Transduction
-
測定原理：quantitative
-
測定方法：Competitive
-
精密度：
Intra-assay Precision (Precision within an assay): CV%<15% Three samples of known concentration were tested twenty times on one plate to assess. Inter-assay Precision (Precision between assays): CV%<15% Three samples of known concentration were tested in twenty assays to assess. -
線性度：
To assess the linearity of the assay, samples were spiked with high concentrations of human PG-E2 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay. Sample Serum(n=4) 1:1 Average % 95 Range % 91-99 1:2 Average % 92 Range % 86-96 1:4 Average % 97 Range % 92-103 1:8 Average % 84 Range % 80-88 -
回收率：
The recovery of human PG-E2 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section. Sample Type Average % Recovery Range Serum (n=5) 94 89-98 EDTA plasma (n=4) 90 83-94 -
標準曲線：
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed. 
pg/ml OD1 OD2 Average 300 0.193 0.201 0.197 75 0.349 0.327 0.338 24 0.523 0.531 0.527 6 0.903 0.962 0.933 1.5 1.316 1.393 1.355 0 2.271 2.212 2.242 -
數據處理：
-
貨期：3-5 working days
引用文獻
- Drug-loaded indocyanine green J-aggregates activate metalloimmunotherapy for sustained photothermal therapy of hepatocellular carcinoma K He, D Chen, D Zhu, W Zheng, L Lyu,Journal of Nanobiotechnology,2025
- Therapeutic Framework Nucleic Acid Complexes Targeting Oxidative Stress and Pyroptosis for the Treatment of Osteoarthritis J Li, Y Li, X Shang, S Xu, Z Zhang, S Xu, X Wang,Materials Today Bio,2024
- Expression analysis of genes and MicroRNAs involved in recurrent implantation failure: New noninvasive biomarkers of implantation B Habibi,Biomedical and Biotechnology Research Journal (BBRJ),2023
- Prodigiosin/celecoxib-loaded into zein/sodium caseinate nanoparticles as a potential therapy for triple negative breast cancer TU Kwon,Scientific reports,2024
- EPC-exosomal miR-26a-5p improves airway remodeling in COPD by inhibiting ferroptosis of bronchial epithelial cells via PTGS2/PGE2 signaling pathway C Liu,Scientific reports,2023
- Increased expression of cyclooxygenase?2 in synovium tissues and synovial fluid from patients with knee osteoarthritis is associated with downregulated microRNA?758?3p expression Z Liu,Experimental and Therapeutic Medicine,2021
- Anti?inflammatory and anti?rheumatic activities in?vitro of alkaloids separated from Aconitum?soongoricum?Stapf Feicui Zhao,Experimental and Therapeutic Medicine,2021
- Analyses of Clinical Features and Investigations on Potential Mechanisms in Patients with Alzheimer’s Disease and Olfactory Dysfunction Zuo, Li-jun.et al,Journal of Alzheimer\'s Disease,2018
- Increase of Prostaglandin E2 in the Reversal of Ductal Constriction After Polyphenol Restriction Vian I.et al,Ultrasound Obstet Gynecol,2017
- Excessive Iron and α-Synuclein Oligomer in Brain are Relevant to Pure Apathy in Parkinson Disease. Wang F.et al,J Geriatr Psychiatry Neurol.,2016
- Effect and Potential Mechanism of Electroacupuncture Add-On Treatment in Patients with Parkinson?? Disease W Fang. et al,Evidence-Based Complementary and Alternative Medicine,2015
- Effect and Potential Mechanism of Electroacupuncture Add-On Treatment in Patients with Parkinson's Disease Fang Wang. et al,Evidence-Based Complementary and Alternative Medicine,2015
- A procedure for efficient non-viral siRNA transfection of primary human monocytes using nucleofection Scherer O et al,J Immunol Methods,2015
- Expression and possible role of non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) in the human endometrium and endometriosis Seok Kyo Seo et al,Hum. Reprod,2010
產品評價
相關產品
Most popular with customers
-
Human Transforming Growth factor β1,TGF-β1 ELISA kit
Detect Range: 23.5 pg/ml-1500 pg/ml
Sensitivity: 5.8 pg/ml
-
-
-
Mouse Tumor necrosis factor α,TNF-α ELISA Kit
Detect Range: 7.8 pg/ml-500 pg/ml
Sensitivity: 1.95 pg/ml
-
-
-
-
